Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.11 USD | -0.22% |
|
+5.72% | +2.21% |
01:06pm | JPMorgan Adjusts Price Target on Incyte to $59 From $60, Maintains Neutral Rating | MT |
12:55pm | Goldman Sachs Adjusts Price Target on Incyte to $61 From $60, Maintains Neutral Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.21% | 14.45B | |
+7.40% | 101B | |
+7.76% | 42.18B | |
-13.23% | 32.26B | |
+81.12% | 29.79B | |
-11.84% | 16.06B | |
-6.77% | 12.01B | |
+182.74% | 10.71B | |
+4.79% | 8.89B | |
-56.23% | 8.83B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Goldman Sachs Adjusts Price Target on Incyte to $61 From $60, Maintains Neutral Rating